LEGISLATIVE BUDGET BOARD

Austin, Texas

FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION

March 27, 2023

TO:	Honorable Tom Oliverson, Chair, House Committee on Insurance
FROM:	Jerry McGinty, Director, Legislative Budget Board
IN RE:	HB755 by Johnson, Julie (Relating to prior authorization for prescription drug benefits related to the treatment of chronic and autoimmune diseases.), As Introduced

No significant fiscal implication to the State is anticipated.

Based on information provided by The Texas University System and the Texas A&M System, implementation of the bill could impact medical plans resulting in a significant costs to institutional funds. Institutional Funds are not appropriated in the General Appropriations Act, and therefore not a cost to the State. 

The bill would amend the Insurance Code to prohibit a health benefit plan from requiring an enrollee to obtain more than one prior authorization annually of the prescription drug benefit for a prescription drug prescribed to treat a chronic or autoimmune disease. It is assumed any costs associated with the bill would be implemented within existing resources.

 

Based on information provided by The Texas University System and the Texas A&M System, implementation of the bill could impact medical plans resulting in a significant costs to institutional funds. Institutional Funds are not appropriated in the General Appropriations Act, and therefore not a cost to the State.

Local Government Impact

No significant fiscal implication to units of local government is anticipated.

Source Agencies:

323 Teacher Retirement System, 327 Employees Retirement System, 454 Department of Insurance, 529 Health and Human Services Commission, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration

LBB Staff:

JMc, AAL, JSM, GO, JPO